ConductScience.org, home

Paper40238917

Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.

Trepka KR and 18 others. Sci Transl Med, 2025. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Papers, record 40238917. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40238917

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.
PubMed
Journal
Sci Transl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Observational Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
3.79, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
Colorectal NeoplasmsMajor topic
FluorouracilMajor topic
OperonMajor topic
PyrimidinesMajor topic
Animals
Female
Humans
Male
Mice
Gastrointestinal Microbiome
RNA, Ribosomal, 16S

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 HL165106NHLBI NIH HHSUnited StatesK08HL165106PubMedNIH RePORTER
R01 CA255116NCI NIH HHSUnited StatesR01CA255116PubMed and NIHNIH RePORTER
T32 AI060537NIAID NIH HHSUnited StatesT32AI060537PubMedNIH RePORTER
R01 DK114034NIDDK NIH HHSUnited StatesR01DK114034PubMed and NIHNIH RePORTER
F30 CA257378NCI NIH HHSUnited StatesF30CA257378PubMed and NIHNIH RePORTER
R01 HL122593NHLBI NIH HHSUnited StatesR01HL122593PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04054908Gut Microbiome in Colorectal CancerDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of38895199Expansion of a bacterial operon during cancer treatment ameliorates drug toxicity.https://conductscience.org/library/papers/38895199

Source PubMed

Download CSV of comments and corrections

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127214047DADA2: High-resolution sample inference from Illumina amplicon data.Nat Methods2016https://conductscience.org/library/papers/27214047PubMed
237602831Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade.Cancer Res2023https://conductscience.org/library/papers/37602831PubMed
335228751Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.Nat Med2022https://conductscience.org/library/papers/35228751PubMed
421414208pROC: an open-source package for R and S+ to analyze and compare ROC curves.BMC Bioinformatics2011https://conductscience.org/library/papers/21414208PubMed
510555122A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug.Invest New Drugs1999https://conductscience.org/library/papers/10555122PubMed
624167597Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines.PLoS One2013https://conductscience.org/library/papers/24167597PubMed
733805100An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities.Cancers (Basel)2021https://conductscience.org/library/papers/33805100PubMed
832835356Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.J Natl Cancer Inst2021https://conductscience.org/library/papers/32835356PubMed
937165188Profiling the human intestinal environment under physiological conditions.Nature2023https://conductscience.org/library/papers/37165188PubMed
1037072662Oral Capecitabine Exposures and Use of Uridine Triacetate: A 20-Year Retrospective Analysis.Clin Drug Investig2023https://conductscience.org/library/papers/37072662PubMed
1121487324Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.Pancreas2011https://conductscience.org/library/papers/21487324PubMed
1210071185Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.Hum Genet1999https://conductscience.org/library/papers/10071185PubMed
1322935759The determination and interpretation of the therapeutic index in drug development.Nat Rev Drug Discov2012https://conductscience.org/library/papers/22935759PubMed
1436347964Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil.Br J Cancer2023https://conductscience.org/library/papers/36347964PubMed
1525640272Role of ABC transporters in fluoropyrimidine-based chemotherapy response.Adv Cancer Res2015https://conductscience.org/library/papers/25640272PubMed
1638470044Anaerostipes hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil.mSphere2024https://conductscience.org/library/papers/38470044PubMed
1738429524A gut microbial signature for combination immune checkpoint blockade across cancer types.Nat Med2024https://conductscience.org/library/papers/38429524PubMed
1832707991In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase.J Clin Med2020https://conductscience.org/library/papers/32707991PubMed
1941853500Spatially and temporally precise microbiome profiling in the small intestine using the SIMBA capsule with X-ray tracking.Front Microbiomes2024https://conductscience.org/library/papers/41853500PubMed
2033944776Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3.Elife2021https://conductscience.org/library/papers/33944776PubMed

See all 79 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42930589From Dysbiosis to Symbiosis: Using the Gut Microbiome to Improve Cancer Outcomes.Med Sci (Basel)2026https://conductscience.org/library/papers/42930589PubMed
42898560Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions.Front Immunol2026https://conductscience.org/library/papers/42898560PubMed
42872031Gut Microbial Metabolism Inactivates Trifluridine and Drives Loss of Anticancer Efficacy.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42872031PubMed
42807681Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions.Front Oncol2026https://conductscience.org/library/papers/42807681PubMed
42375360Molecular studies on the impact of microbiome on anticancer drug resistance.Front Immunol2026https://conductscience.org/library/papers/42375360PubMed
42147160Eggerthella lenta evades bacteriophage through reversible megabase-scale inversions of capsular polysaccharide gene clusters.Res Sq2026https://conductscience.org/library/papers/42147160PubMed
42079178Eggerthella lenta evades bacteriophage through reversible megabase-scale inversions of capsular polysaccharide gene clusters.bioRxiv2026https://conductscience.org/library/papers/42079178PubMed
41959463A widespread gut bacterial lineage distinguished by redox metabolism and phage defense.bioRxiv2026https://conductscience.org/library/papers/41959463PubMed
41758194Exploring the gut microbiome and metabolomic interactions of antimetabolite drugs to optimize therapy.Gut Microbes2026https://conductscience.org/library/papers/41758194PubMed
41595591Advances in Understanding the Impact of Human Gut Microbiota on Chemotherapy-Induced Neutropenia.Biomedicines2025https://conductscience.org/library/papers/41595591PubMed
41497648Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent.bioRxiv2025https://conductscience.org/library/papers/41497648PubMed
41486395Harnessing the microbiome for cancer therapy.Nat Rev Microbiol2026https://conductscience.org/library/papers/41486395PubMed
40824448A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.Cancer Chemother Pharmacol2025https://conductscience.org/library/papers/40824448PubMed
40391895Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity.mBio2025https://conductscience.org/library/papers/40391895PubMed

Download CSV of cited by

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
BioProjectPRJNA1169175

Source BioProject

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40238917

GET https://conductscience.org/api/papers/v1/40238917/references?page=2